Type
1.
Nisha, Shanthi. Characterization of Ofloxacin Interaction with Mutated (A91V) Quinolone Resistance Determining Region of DNA Gyrase in Mycobacterium Leprae through Computational Simulation. Cell biochemistry and biophysics. 2017;
Type
1.
Thangaraju P, Venkatesan S, MK SA. Minocycline: A strategy for unresponsive nerve function impairment. Dermatologic therapy. 2017;
Type
1.
Naumov A, Ovsyannikova O, Pankrashova E, Shishkina T, Naumova L. The role of cytokines in the formation of morphological changes in the skin with leprosy. Archiv Euromedica [Internet]. 2017;7(1):50-2. Available from: http://www.ewg-board.eu/archiv-euromedica/euromedica_01_2017/archiv_euromedica_01_2017_maket_30_07_2017_WEB_50_52.pdf
Type
1.
Semwal S, Joshi D, Goel G, Kapoor N, Asati D. Clinico-histological correlation in Hansen’s disease: Three-year experience at a newly established tertiary care center in central India. Indian journal of dermatology [Internet]. 2018;63(6):465-8. Available from: http://www.e-ijd.org/article.asp?issn=0019-5154;year=2018;volume=63;issue=6;spage=465;epage=468;aulast=Semwal
Type
1.
O’Brien C, Malik R, Globan M, Reppas G, McCowan C, Fyfe J. Feline leprosy due to Candidatus ’Mycobacterium lepraefelis’: Further clinical and molecular characterisation of eight previously reported cases and an additional 30 cases. Journal of feline medicine and surgery. 2017;19(9):919-32.
Type
1.
Tarique M, Saini C, Naz H, Naqvi RA, Khan FI, Sharma A. Fate of T cells and their secretary proteins during the progression of leprosy. Current protein & peptide science. 2017;18.
Type
1.
Bailey MA, Na H, Duthie MS, Gillis T, Lahiri R, Parish T. Nitazoxanide is active against Mycobacterium leprae. PloS one [Internet]. 2017;12(8):e0184107. Available from: http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0184107&type=printable
Type
1.
Madigan C, Cambier, Kelly-Scumpia K, Scumpia P, Cheng T-Y, Zailaa J, et al. A Macrophage Response to Mycobacterium leprae Phenolic Glycolipid Initiates Nerve Damage in Leprosy. Cell [Internet]. 2017;170(5):973-85. Available from: http://www.cell.com/cell/pdf/S0092-8674(17)30866-8.pdf
Type
1.
Yagüe S. P249 LEPS abnormalities in the evaluation of dyspigmented and hypoesthetic patches in tuberculoid leprosy. Clinical neurophysiology. 2017;128(9):e258.
Type
1.
Hadi MI, Faizah H, Alamudi MY. The Overview of Anti-PGL-1 and Anti-IDALLE L-ESAT 6 IgG Antibody Titers in Household Contact of Leprosy. International Conference on Sustainable Health Promotion [Internet]. 2018;:1-4. Available from: http://proceedings.uinsby.ac.id/index.php/ICOSHPRO/article/view/3/1